Press Releases

Date Title and Summary Additional Formats
Toggle Summary ArQule Announces Initiation of Two Phase 2 Trials with c-Met Inhibitor, ARQ 197
Trials target MiT tumors and pancreatic cancer
View HTML
Toggle Summary ArQule, Inc. to Present at the CIBC and Rodman & Renshaw Healthcare Conferences on November 5-6, 2007
Rodman & Renshaw live web cast scheduled for November 5, 10:35 p.m. eastern time; CIBC live web cast scheduled for November 6, 8:35 a.m. eastern time
View HTML
Toggle Summary ArQule, Inc. to Report Third Quarter 2007 Financial Results on November 1, 2007
Conference call and Webcast scheduled for 9:00 a.m. Eastern Time
View HTML
Toggle Summary Arqule Announces Clinical and Pre-Clinical Data on Anti-Metastatic Potential of ARQ 197, a Selective c-Met Inhibitor
Posters presented at AACR-NCI-EORTC International Conference
View HTML
Toggle Summary ArQule Names Peter Lawrence Chief Operating Officer
ArQule Names Peter Lawrence Chief Operating Officer WOBURN, Mass.--(BUSINESS WIRE)--Oct. 8, 2007--ArQule, Inc. (Nasdaq: ARQL) today announced that Peter S. Lawrence has been appointed chief operating officer. Mr. Lawrence was previously executive vice president, chief business officer and general
View HTML
Toggle Summary ArQule, Inc. to Present at BIO Investor Forum Conference on October 11, 2007
Live web cast scheduled for 2:30 p.m. eastern time
View HTML
Toggle Summary ArQule, Inc. to Present at UBS Global Life Sciences Conference on September 24, 2007
Live web cast scheduled for 2:00 p.m. eastern time
View HTML
Toggle Summary ArQule Reports Second Quarter 2007 Financial Results
ArQule Reports Second Quarter 2007 Financial Results WOBURN, Mass., Aug 02, 2007 (BUSINESS WIRE) -- ArQule, Inc. (NASDAQ: ARQL) today announced its financial results for the second quarter of 2007. For the quarter ended June 30, 2007, the Company reported a net loss of $13,361,000 or $0.36 per
View HTML
Toggle Summary ArQule, Inc. to Report Second Quarter 2007 Financial Results on August 2, 2007
Conference call and Webcast scheduled for 9:00 a.m. Eastern Time
View HTML
Toggle Summary ArQule Announces Exercise of over-Allotment Option
ArQule Announces Exercise of over-Allotment Option WOBURN, Mass.--(BUSINESS WIRE)--July 18, 2007--ArQule, Inc. ("ArQule" or the "Company") (NASDAQ: ARQL) today announced the closing of the purchase of an additional 502,000 shares of the Company's common stock pursuant to the underwriters' partial
View HTML

Questions or Concerns?

Please feel free to contact by one of the methods below

Online Form   Call (781) 994-0300

These archived presentations and related materials are provided for reference by ArQule, Inc. Information contained in the materials was current only as of the date of the event. ArQule, Inc. does not update or delete outdated information contained in these materials, and it expressly disclaims any obligation to do so. The materials are property of ArQule, Inc. and any use, dissemination or republication of the files is prohibited without the express written consent of ArQule, Inc.